This new cooperation agreement, according to Movianto, eliminates the market-entry barrier for Movianto. Thomas Creuzberger, CEO of Movianto:
“To implement our approach to tailored logistics solutions across Europe, we had to decide whether to build our own network in Portugal or rely on a proven partner in this country who meets our quality standards. With the recently signed cooperation agreement, we save time to market, as we can offer solutions
for integrating the Portuguese market much faster than by building our own organization.”
Distribution bound to a warehouse in Portugal
In Portugal, the distribution of most medical goods is bound to storage in a warehouse located in the country. Therefore, for example, it cannot be organized from Spain, it continues. They are required to possess storage and distribution capacities in Portugal themselves in accordance with GDP standards for the pharmaceutical
and healthcare sector.
Rangel had launched the network in Portugal in 2009 and, according to its own statements, developed into the national market leader for this industry. The company offers warehouse infrastructure for pharmaceutical and healthcare products that require storage conditions between 15 degrees and 25 degrees Celsius or between 2 and 8 degrees Celsius, as well as for psychopharmaceuticals, clinical trials, and products for veterinary use.
A nationwide cold-chain
transport network with active temperature control at two to eight degrees Celsius distributes medicines and pharmaceutical products stored in one of Rangel's specialized pharmaceutical warehouses in the country. Nuno Rangel, Vice President and CEO of Rangel:
“Through the cooperation agreement, both companies not only expand their geographic reach, but also gain the opportunity to participate in a growing number of tenders where it is a prerequisite to offer a cross-border
